Societe Generale’s Pfizer PFE Stock Holding History

Societe Generale’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$1.57M	Buy	+1,095,211	New	+$35M	0.01%	1001

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Societe Generale's PFE Position: Q2 2016 in Review

Societe Generale opened a new position in Pfizer (PFE) in Q2 2016: 344,837 shares worth $11.5M. The stake represents 0.08% of the portfolio and ranks #183 among its holdings.

1,991 funds tracked by Wall St. Rank hold PFE as of Q2 2016.

Societe Generale held 344,837 shares of Pfizer worth $11.5M as of Q2 2016.
Pfizer was a new Societe Generale position in Q2 2016.
Pfizer made up 0.08% of Societe Generale's portfolio in Q2 2016, its #183 holding.
1,991 funds tracked by Wall St. Rank held Pfizer as of Q2 2016.

Based on Societe Generale's 13F filing for Q2 2016, filed 2 Aug 2016.